Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum AIkido Pharma SPEX

Healthcare Biotechnology
AIkido Pharma Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).

NDAQ:SPEX - Post Discussion

AIkido Pharma > Terrible game played by this company
View:
Post by taff3 on Apr 14, 2020 3:50pm

Terrible game played by this company

Especially for the longs who held through the name change but they were rewarded today with great news AIkido Pharma Executes Exclusive World-Wide License to Broad Spectrum Antiviral Drug Platform, Includes Coronavirus

Then watch your stock grow to $2.75 only to follow it up with a 14,000,000 offering at a friggin $1.00 and then take it down to .80
Then you talk about share holder value. I don’t think so.
 

Comment by fnapts on Feb 23, 2021 11:13pm
They closed a $86.2 million bought deal at $1.60 (upsized from $10 million) without warrants. Seriously?
Comment by fnapts on Feb 24, 2021 2:31pm
Bought in PM. Wish I saw this a couple days ago, I would have loaded up on those shares that sold near $1.
Comment by fnapts on Feb 25, 2021 12:27pm
This is silly. $86.2 million invested at $1.60, now trading at a 20% discount.
AIkido Pharma
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities